Effect of UUO on D1aR expression reveals a link among dopamine, transforming growth factor-β, and nitric oxide

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Stern, Joshua M ^a   Chen, Jie ^a   Silver, Randi B ^b   Poppas, Dix P ^a   Vaughan, E Darracott ^a   Felsen, Diane ^a,b  

^a New York Presbyt Children's Hosp   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; D1A receptor; Kidney; Obstructive uropathy; Unilateral ureteral obstruction

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1A RECEPTOR; MONOCLONAL ANTIBODY; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DOPAMINE D1A RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OBSTRUCTIVE UROPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; UNILATERAL URETER OBSTRUCTION; URETER OBSTRUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; KIDNEY PROXIMAL TUBULE; METABOLISM; MOUSE; MOUSE MUTANT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL LINE; DOPAMINE; KIDNEY TUBULES, PROXIMAL; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 1542530333     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00253.2002     Document Type: Article

References (38)

1. Carey RM. Renal dopamine system-paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38: 297-302, 2001.
2. Cheng HF, Becker BN, and Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97: 2745-2752, 1996.
3. Communal C, Singh K, Pimentel DR, and Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98: 1329-1334, 1998.
4. Denton MD, Chertow GM, and Brady HR. "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 50: 4-14, 1996.
5. 1 in experimental hydronephrosis. Am J Physiol Renal Fluid Electrolyte Physiol 266: F926-F933, 1994.
6. Felder RA, Seikaly MG, Cody P, Eisner GM, and Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990.
7. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, and Chevalier RL. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103: 39-46, 1998.
8. Glickstein SB and Schmauss C. Dopamine receptor functions: lessons from knockout mice. Pharmacol Ther 91: 63-83, 2001.
9. A1 dopamine receptor. Am J Physiol Renal Fluid Electrolyte Physiol 260: F906-F912, 1991.
10. Gulmi FA, Felsen D, and Vaughan ED Jr. Pathophysiology of urinary tract obstruction. In: Campbell's Urology, edited by Walsh PC, Retik AB, Vaughan ED Jr, and Wein AJ. Philadelphia, PA: Saunders, 2002, p. 411-463.
11. 1A receptor mRNA in renal epithelial cells are mediated by nitric oxide. Acta Physiol Scand 169: 233-238, 2000.
12. Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan ED Jr, Poppas DP, and Felsen D. Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase (Abstract). Lab Invest 80: 1721, 2000.
13. 2 in dopamine-1 receptor mediated cellular signaling mechanisms in the proximal tubules of SHR. Clin Exp Hypertens 19: 131-140, 1997.
14. q/11 proteins in spontaneously hypertensive rats. Am J Physiol Renal Physiol 272: F39-F46, 1997.
15. 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58: 1885-1892, 2000.
16. Ishidoya S, Morrissey JJ, McCracken R, Reyes A, and Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995.
17. Jose PA, Eisner GM, and Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002.
18. 1 mRNA in the obstructed kidney of rats with unilateral ureteral obstruction. Kidney Int 44: 313-321, 1993.
19. Klahr S. Obstructive nephropathy. Kidney Int 54: 286-300, 1998.
20. Lash LH, Putt DA, and Matherly LH. Protection of NRK-52E cells, a rat renal proximal tubular cell line, from chemical-induced apoptosis by overexpression of a mitochondrial glutathione transporter. J Pharm Exp-Ther 303: 476-486, 2002.
21. Matsuo T. Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells. Br J Ophthalmol 84: 631-635, 2000.
22. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern JM, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED Jr, and Felsen D. Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313, 2000.
23. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr, and Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59: 1290-1303, 2001.
24. Morrissey JJ, Ishidoya S, McCracken R, and Klahr S. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7: 2202-2212, 1996.
25. 1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol Renal Physiol 274: F232-F241, 1998.
26. 1A receptor protein in rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1185-F1197, 1995.
27. Pratt BM and McPherson JM. TGFβ in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev 8: 267-292, 1997.
28. Sheikh-Hamad D, Wang YP, Jo OD, and Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol Renal Fluid Electrolyte Physiol 264: F737-F743, 1993.
29. Silver RB. Ratio imaging: practical considerations for measuring intracellular calcium and pH in living tissue. Methods Cell Biol 56: 237-251, 1998.
30. Truong LD, Sheikh-Hamad D, Chakraborty S, and Suki WN. Cell apoptosis and proliferation in obstructive uropathy. Semin Nephrol 18: 641-651, 1998.
31. Tseng L, Mazella J, Goligorsky MS, Rialas CM, and Stefano GB. Dopamine and morphine stimulate nitric oxide release in human endometrial glandular epithelial cells. J Soc Gynecol Invest 7: 343-347, 2000.
32. Vaughan ED Jr, Sorenson EJ, and Gillenwater JY. The renal hemodynamic response to chronic unilateral complete occlusion. Invest Urol 8: 78-90, 1970.
33. Walton G, Buttyan R, Garcia-Montes E, Olsson CA, Hensle TW, and Sawczuk IS. Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148: 510-514, 1992.
34. 1 dopamine receptor agonist SKF-82958 in mouse striatum. Neurosci Lett 311: 5-8, 2001.
35. 1A receptor induces antinatriuresis in conscious rats. Hypertension 33: 504-510, 1999.
36. Yu XC, Wang HX, Pei JM, and Wong TM. Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31: 1809-1819, 1999.
37. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42: 787-792, 2003.
38. Zhou W, Cunningham K, and Thomas M. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res Mol Brain Res 100: 75-83, 2002.